Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of LY3437943 in Participants Who Have Obesity or Are Overweight

ClinicalTrials.gov ID: NCT04881760

Public ClinicalTrials.gov record NCT04881760. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities

Study identification

NCT ID
NCT04881760
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
338 participants

Conditions and interventions

Interventions

  • LY3437943 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 19, 2021
Primary completion
May 15, 2022
Completion
Nov 21, 2022
Last update posted
Sep 12, 2023

2021 – 2022

United States locations

U.S. sites
25
U.S. states
13
U.S. cities
24
Facility City State ZIP Site status
Perseverance Research Center Scottsdale Arizona 85254
Anaheim Clinical Trials, LLC Anaheim California 92801
Valley Research Fresno California 93720
Velocity Clinical Research, Huntington Park Huntington Park California 90255
Velocity Clinical Research, Huntington Park Los Angeles California 90057
Southern California Dermatology, Inc. Santa Ana California 92701
Coastal Metabolic Research Centre Ventura California 93003
Diablo Clinical Research, Inc. Walnut Creek California 94598
East Coast Institute for Research, LLC Jacksonville Florida 32216
Suncoast Clinical Research, Inc. New Port Richey Florida 34652
Encore Medical Research - Weston Weston Florida 33331
Springfield Diabetes & Endocrine Center Springfield Illinois 62711
Cotton O'Neil Diabetes and Endocrinology Center Topeka Kansas 66606
Tandem Clinical Research,LLC Marrero Louisiana 70072
StudyMetrix Research City of Saint Peters Missouri 63303
Amici Clinical Research LLC Raritan New Jersey 08869
Intend Research, LLC Norman Oklahoma 73069
Allegheny Endocrinology Associates Pittsburgh Pennsylvania 15212
New Phase Research and Development Knoxville Tennessee 37909
Texas Diabetes & Endocrinology, P.A. Austin Texas 78731
Dallas Diabetes Research Center Dallas Texas 75230
Juno Research Houston Texas 77054
Endocrine Ips, Pllc Houston Texas 77079
Southern Endocrinology Associates Mesquite Texas 75149
Rainier Clinical Research Center Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04881760, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 12, 2023 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04881760 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →